Search results for PX-TA1314
Showing 1 – 10 of1products

ID: BAB119510867
Seribantumab Biosimilar – Anti-ERBB3 mAb – Research Grade, ProteoGenix, PX-TA1314
Description of Seribantumab Biosimilar - Anti-ERBB3 mAb - Research Grade General information on Anti-ERBB3[Homo sapiens] (Seribantumab) Monoclonal Antibody Seribantumab has been investigated for the treatment of NSCLC, Heregulin, Adenocarcinoma, Colorectal Cancer, and Solid Tumor Cancers.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
